| dc.contributor.author |
Mahesh, R. |
|
| dc.date.accessioned |
2023-11-21T10:43:34Z |
|
| dc.date.available |
2023-11-21T10:43:34Z |
|
| dc.date.issued |
2014 |
|
| dc.identifier.uri |
https://www.degruyter.com/document/doi/10.1515/jbcpp-2013-0160/html |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13205 |
|
| dc.description.abstract |
The inconsistent therapeutic outcome necessitates designing and identifying novel therapeutic interventions for depression. Hence, the present study deals with the investigation of antidepressant-like effects of a novel 5-HT3 receptor antagonist (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a) on chronic unpredictable mild stress (CUMS) induced behavioral and biochemical alterations. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
De Gruyter |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
Antagonists |
en_US |
| dc.subject |
5-HT3 antagonist |
en_US |
| dc.subject |
Chronic unpredictable mild stress (CUMS) |
en_US |
| dc.subject |
Sucrose preference |
en_US |
| dc.subject |
Oxidative stress |
en_US |
| dc.title |
Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery |
en_US |
| dc.type |
Article |
en_US |